PRKAA1 and metabolic dysfunction-associated steatotic liver disease: Resveratrol ameliorates NAFLD by upregulating the hepatic LDLr and SR-BI gene expression, significantly reducing tumor necrosis factor-α (TNF-α) levels, and activating the AMPK/SIRT1 and anti-inflammatory signaling pathways [99,100].